{"issuance_frequency":"","notes_translated":{"fr":"Recherche: Aperçu de la filière de candidats vaccins contre le virus respiratoire syncytial au Canada. Relevé des maladies transmissibles au Canada (RMTC), Volume 46–4, le 2 avril 2020 : Virus respiratoire syncytial (VRS).","en":"Research: Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada. Published on Canada Communicable Disease Report (CCDR), volume 46-4, April 2, 2020."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"54e158bb-e124-49d3-8d9b-29f58dca4495","metadata_created":"2020-05-11T12:10:40.276643","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-05-11T12:10:40.276649","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-05-11","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Virus respiratoire syncytial","vaccin","Relevé des maladies transmissibles au Canada"],"en":["Respiratory syncytial virus","vaccine","Canda Communicable Disease Report."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Défis en matière de création d’un vaccin contre le virus respiratoire syncytial","en":"Challenges to developing a vaccine for respiratory syncytial virus"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"54e158bb-e124-49d3-8d9b-29f58dca4495","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a0186a33-63bf-4ab9-96ec-5b87e942d7c1","related_relationship":"","name_translated":{"fr":"Défis en matière de création d’un vaccin contre le virus respiratoire syncytial","en":"Challenges to developing a vaccine for respiratory syncytial virus"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Challenges to developing a vaccine for respiratory syncytial virus","language":["en"],"created":"2020-05-11T12:10:40.409764","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-1-challenges-developing-vaccine-respiratory-syncytial-virus.html","last_modified":null,"position":0,"revision_id":"99bee170-6b2a-40ee-9a01-8a09fcc837d4","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"54e158bb-e124-49d3-8d9b-29f58dca4495","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e2009aae-d6ca-43e4-add0-43bde68d7be0","related_relationship":"","name_translated":{"fr":"Défis en matière de création d’un vaccin contre le virus respiratoire syncytial","en":"Challenges to developing a vaccine for respiratory syncytial virus"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Challenges to developing a vaccine for respiratory syncytial virus","language":["fr"],"created":"2020-05-11T12:10:40.409770","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-1-defis-matiere-creation-vaccin-contre-virus-respiratoire-syncytial.html","last_modified":null,"position":1,"revision_id":"99bee170-6b2a-40ee-9a01-8a09fcc837d4","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2020-04-02 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"54e158bb-e124-49d3-8d9b-29f58dca4495","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Research: Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada. Published on Canada Communicable Disease Report (CCDR), volume 46-4, April 2, 2020.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Challenges to developing a vaccine for respiratory syncytial virus","revision_id":"99bee170-6b2a-40ee-9a01-8a09fcc837d4"}